MedTrace Logo

Esophagogastrectomy Versus Extended Gastrectomy in AEG II

NCT02302118 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2015-12-03

No results posted yet for this study

Summary

Comparison of the oncological outcome of patients who underwent esophagogastrectomy versus extended gastrectomy due to carcinomas of the esophagogastric junction (Siewert type II)

Conditions

  • Carcinomas of the Esophagogastric Junction

Interventions

PROCEDURE

Esophagogastrectomy

Esophagogastrectomy

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Jakob R Izbicki, MD · Universitätsklinikum Hamburg-Eppendorf

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-10-31
Completion
2015-11-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02302118 on ClinicalTrials.gov